WCM Investment Management
BPMC

WCM Investment Management’s Blueprint Medicines BPMC Stock Holding History

WCM Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-37,339
Closed -$2.99M – 183
2019
Q4 		$2.99M Buy
37,339
+31,844
+580% +$2.38M 0.02% 136
2019
Q3 		$404K Hold
5,495
– – ﹤0.01% 145
2019
Q2 		$518K Buy
+5,495
New +$454K ﹤0.01% 141

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WCM Investment Management's BPMC Position: Q1 2020 in Review

WCM Investment Management sold out of Blueprint Medicines (BPMC) in Q1 2020, closing a stake of 37,339 shares — an estimated $2.99M sold.

WCM Investment Management first reported a position in BPMC in Q2 2019 and held it in 3 quarters. The position peaked at $2.99M in Q4 2019. 214 funds tracked by Wall St. Rank hold BPMC as of Q1 2020.

  • WCM Investment Management reported no remaining Blueprint Medicines position as of Q1 2020 after selling out during the quarter.
  • WCM Investment Management sold 37,339 Blueprint Medicines shares in Q1 2020, an estimated $2.99M.
  • WCM Investment Management first reported a position in Blueprint Medicines in Q2 2019 and held it in 3 quarters.
  • WCM Investment Management's Blueprint Medicines position peaked at $2.99M in Q4 2019.
  • 214 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2020.

Based on WCM Investment Management's 13F filing for Q1 2020, filed 8 May 2020.